Ampio Pharmaceuticals, Inc. (AMPE) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to NPO Pharmaceuticals 2021 third quarter earnings result and corporate update call. I will be the event specialist running today's event. If you would like to ask a question today, please submit your questions on the webcast platform via the ask a question widget on the top right hand corner of your screen. As a reminder, this call is being recorded and all listeners will be on a listen only mode. At this time, I would like to turn the call over to Mr Dan Stokely, and PO's chief financial officer. Dan, please go ahead when you're ready. Hi, everyone. Thank you very much, and I hope everyone's having a great day. It's our pleasure for me and certain members of the executive management team to be present today, and we'd like to thank each one of you for attending our third quarter 2021 earnings and business update call. Prior to reading the Safe Harbor forward-looking statement, I would like to introduce you to the members of the executive team who will be presenting and or participating on the call today. First is Holly Cherevka, the company's president and chief operating officer. We also have President Howard Levy, the company's chief medical officer, Dr. David Baror, director and founder, and myself, Dan Stokely, the chief financial officer. I'd like to start out by first reading our safe harbor statement. The presentation and any follow-up responses to Q&A may contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements, as these statements are based upon our current expectations, forecasts, and assumptions, and are subject to significant risks and uncertainties. These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, beli...